Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jiangsu Pengqing Medical Technology Co. Ltd. has 1 pending office action in the Chemistry & Materials technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit, indicating a highly concentrated prosecution effort. For a company in this sector, having a single pending matter allows for a very focused approach to patent strategy. This concentration ensures that all legal resources are directed toward a single set of examiner concerns.
GROSS, CARSON is the busiest examiner for the company, managing 1 pending office action. As the only examiner currently reviewing the company's applications, this individual's perspective is paramount. The company can tailor its responses specifically to the stylistic preferences of this 1 distinct examiner. This 1 pending office action represents the full extent of the company's current activity at the office as shown in the data.
With only 1 distinct art unit involved, the company avoids the complexity of navigating different procedural norms across the office. This 1 pending office action provides a streamlined path for the company to pursue its intellectual property goals. The lack of examiner or art unit diversity means that the company's current prosecution is entirely unified. This focused structure is ideal for managing a small number of high-priority filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GROSS, CARSON | 1 | 73.0% | +21.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694988 | MEDICAL PAPER PRODUCTION APPARATUS AND PRODUCTION PROCESS | GROSS, CARSON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694988 | MEDICAL PAPER PRODUCTION APPARATUS AND PRODUCTION PROCESS | GROSS, CARSON | — |
| Art Unit | Apps |
|---|---|
| 1746 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694988 | MEDICAL PAPER PRODUCTION APPARATUS AND PRODUCTION PROCESS | GROSS, CARSON | 1746 | §103§112 | Non-Final OA | — | Pending | Mar 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJiangsu Pengqing Medical Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Carson Gross has the most, with 1 of Jiangsu Pengqing Medical Technology Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
